仔细考虑抑制胆固醇酯转运蛋白（CETP）的可能性。 - Suppr

Suppr

超能文献

Mulling over the odds of CETP inhibition.

作者信息

von Eckardstein Arnold

出版信息

Eur Heart J. 2010 Feb;31(4):390-3. doi: 10.1093/eurheartj/ehp394. Epub 2010 Jan 22.

DOI:10.1093/eurheartj/ehp394

PMID:20097704

Abstract

摘要

相似文献

Mulling over the odds of CETP inhibition.

Eur Heart J. 2010 Feb;31(4):390-3. doi: 10.1093/eurheartj/ehp394. Epub 2010 Jan 22.

Future of cholesteryl ester transfer protein inhibitors.

Annu Rev Med. 2014;65:385-403. doi: 10.1146/annurev-med-050311-163305.

CETP inhibition in perspective.

Atherosclerosis. 2012 Feb;220(2):325-8. doi: 10.1016/j.atherosclerosis.2011.10.008. Epub 2011 Oct 14.

[HDL and CETP in atherogenesis].

Dtsch Med Wochenschr. 2010 Feb;135(5):188-92. doi: 10.1055/s-0030-1247862. Epub 2010 Jan 15.

Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme.

Eur Heart J. 2012 Jul;33(14):1712-5. doi: 10.1093/eurheartj/ehs182. Epub 2012 Jun 13.

Are human CETP mutations and CETP-inhibiting drugs a good or a bad deal?

J Mol Med (Berl). 2006 Aug;84(8):625-7. doi: 10.1007/s00109-006-0071-3. Epub 2006 Jul 20.

Cholesteryl ester transfer protein inhibition for coronary heart disease prevention: real hope or despair?

Am J Med. 2008 Aug;121(8):644-6. doi: 10.1016/j.amjmed.2008.02.040.

Is a blood pressure rise the only deleterious off-target effect of cholesterol ester transfer protein inhibitors?

J Hypertens. 2010 Aug;28(8):1614-6. doi: 10.1097/HJH.0b013e32833c575b.

Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case.

Circulation. 2015 Aug 4;132(5):423-32. doi: 10.1161/CIRCULATIONAHA.114.014025.

Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP as a Target to Lower CVD Risk: Suspension of Disbelief?

Circulation. 2015 Aug 4;132(5):433-40. doi: 10.1161/CIRCULATIONAHA.115.014026.

引用本文的文献

Mechanistic systems modeling to guide drug discovery and development.

Drug Discov Today. 2013 Feb;18(3-4):116-27. doi: 10.1016/j.drudis.2012.09.003. Epub 2012 Sep 19.

Rationale for cholesteryl ester transfer protein inhibition.

Curr Opin Lipidol. 2012 Aug;23(4):372-6. doi: 10.1097/MOL.0b013e328353ef1d.

Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein.

Atherosclerosis. 2011 Nov;219(1):109-15. doi: 10.1016/j.atherosclerosis.2011.07.023. Epub 2011 Jul 21.

Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis.

Curr Atheroscler Rep. 2011 Apr;13(2):107-14. doi: 10.1007/s11883-011-0166-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验